Document Detail

Primary patency of Wallstents in malignant bile duct obstruction: single vs. two or more noncoaxial stents.
MedLine Citation:
PMID:  19387728     Owner:  NLM     Status:  MEDLINE    
The purpose of this study was to determine the primary patency of two or more noncoaxial self-expanding metallic Wallstents (Boston Scientific, Natick, MA) and to compare this with the primary patency of a single stent in malignant bile duct obstruction. From August 2002 to August 2004, 127 patients had stents placed for malignant bile duct obstruction. Forty-five patients were treated with more than one noncoaxial self-expanding metallic stents and 82 patients had a single stent placed. Two patients in the multiple-stent group were lost to follow-up. The primary patency period was calculated from the date of stenting until the first poststenting intervention for stent occlusion, death, or the time of last documented follow-up. The patency of a single stent was significantly different from that of multiple stents (P = 0.0004). In the subset of patients with high bile duct obstruction, the patency of a single stent remained significantly different from that of multiple stents (P = 0.02). In the single-stent group, there was no difference in patency between patients with high vs. those with low bile duct obstruction (P = 0.43). The overall median patency for the multistent group and the single-stent group was 201 and 261 days, respectively. In conclusion, the patency of a single stent placed for malignant low or high bile duct obstruction is similar, and significantly longer than, that of multiple stents placed for malignant high bile duct obstruction. Given the median patency of 201 days, when indicated, percutaneous stenting of multiple bile ducts is an effective palliative measure for patients with malignant high bile duct obstruction.
Majid Maybody; Karen T Brown; Lynn A Brody; Anne M Covey; Constantinos T Sofocleous; Raymond H Thornton; George I Getrajdman
Related Documents :
20525708 - Combined airway and oesophageal stenting in malignant airway-oesophageal fistulas: a pr...
17219828 - Primary stent therapy for symptomatic intracranial atherosclerotic stenosis: 1-year fol...
15224298 - Retroinfusion-supported stenting in high-risk patients for percutaneous intervention an...
1112658 - The value of a stent in primary ureteral repair.
773068 - Polyglycolic acid (dexon) versus silk for fascial closure of abdominal incisions.
25122078 - Congenital tibial deficiency: a 37-year experience at 1 institution.
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2009-04-23
Journal Detail:
Title:  Cardiovascular and interventional radiology     Volume:  32     ISSN:  1432-086X     ISO Abbreviation:  Cardiovasc Intervent Radiol     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-07-06     Completed Date:  2009-12-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8003538     Medline TA:  Cardiovasc Intervent Radiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  707-13     Citation Subset:  IM    
Memorial Sloan-Kettering Cancer Center, Interventional Radiology Section, 1275 York Avenue, H118A, New York, NY 10065, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cholestasis / etiology,  pathology,  therapy*
Contrast Media
Digestive System Neoplasms / complications*
Treatment Outcome
Vascular Patency
Reg. No./Substance:
0/Contrast Media

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Chronic portal vein thrombosis after liver transplantation in a child treated by a combined minimall...
Next Document:  Transcatheter Embolization of Bronchial Artery Arising from Left Circumflex Coronary Artery in a Pat...